Introduction
Living with ulcerative colitis often involves managing symptoms over the long term, even when the disease is under control. Many patients experience periods of remission where symptoms improve or disappear, but maintaining that remission can be an important part of preventing future flare-ups and preserving quality of life. Ongoing treatment may help reduce inflammation and support long-term disease management.
Dipentum is a prescription medication used to help maintain remission in adults with ulcerative colitis. As an aminosalicylate anti-inflammatory treatment, it works in the colon to help control inflammation and support continued disease stability. For many patients, maintenance therapy plays a critical role in reducing the risk of symptom recurrence.
Because long-term treatment can become expensive, many patients search for the Dipentum patient assistance program when exploring ways to manage medication costs.
Prescription Hope provides access to patient assistance programs for patients struggling to afford their brand-name medications.
What Is the Dipentum Patient Assistance Program?
Understanding Dipentum Prescription Assistance
Brand-name medication retail costs are sometimes higher than many Americans can afford. Especially those who have inadequate insurance coverage.
Pharmaceutical manufacturers offer patient assistance programs for those who struggle to afford their medications and have inadequate insurance coverage.
Unfortunately, some of these programs may be too difficult to apply for. Patients have reported feeling overwhelmed and frustrated with the process.
How Expert Advocates Help Make Dipentum More Affordable
Personalized Prescription Assistance
Prescription Hope offers medication advocate support to patients applying for patient assistance programs such as the Dipentum Patient Assistance Program.
Our Dipentum enrollment assistance takes care of tasks like completing forms, collecting documents and signatures, communicating with healthcare providers, and coordinating with manufacturers.
Ongoing Patient Support
Prescription Hope’s patient-centered support and prescription affordability assistance doesn’t end with your first shipment of medication. We continue to manage document updates, refill scheduling, yearly renewals, program monitoring, and more.
Dipentum Price Comparison
vs
Estimated Retail Price*
30-Day Supply
Prescription Hope Price
Per Month, NO Matter The Retail Price
*Source: Drugs.com
Navigating Medication Costs
While there are many ways to save on brand-name medication costs, they often come with drawbacks. Things like limited availability, unpredictability, or gaps in coverage means a patient could be stuck with hundreds, if not thousands, of dollars in medication costs every month.
Prescription Hope is not an insurance company, discount card, or coupon. Instead, we offer patients access to patient assistance programs at a clear $70.00 per month, per medication.
We do not charge add-on fees or medication costs. Our monthly service fee is all you pay.
If you do not qualify for your intended program, we will help you find other ways to save, such as substitute medications, discount cards, coupons, or other savings options.
And if we can’t help you save, then you pay nothing.
Dipentum Patient Assistance Eligibility
General Eligibility Requirements
Medication assistance eligibility relies on several general categories. Some of them include:
Insurance coverage: Each program holds its own requirements regarding insurance coverage status.
Income: Every program’s criteria differ regarding the income threshold level.
Prescription: All programs require patients to have a valid prescription for the brand-name medication they wish to qualify for.
US Residency: All applicants must be valid US residents to qualify.
Simple Enrollment With Expert Support
Getting Started
Ready to enroll in Dipentum assistance and looking for our support services during the Dipentum application process?
Prescription Hope’s medication assistance enrollment process is 6 simple steps:
- Submit Information: Enrollment forms only take a few minutes to complete. Simply fill out our form and submit it.
- Advocate Contact: Our team of expert patient advocates will reach out within 1-2 business days after we receive your enrollment form.
- Document Collection: After prequalification, our team gets to work collecting all the needed documents.
- Provider Coordination: We coordinate with healthcare providers to secure necessary signatures.
- Program Submission: Once everything is in order, we submit your application and continue to coordinate with the manufacturer.
- Medication Delivery: Following approval, most patients receive their medication within 2 weeks. All medication ships directly from the manufacturer to your door or doctor’s office.
Understanding Dipentum
How Dipentum Works
Dipentum contains olsalazine sodium, a medication that acts as a prodrug for mesalamine, also known as 5-aminosalicylic acid (5-ASA). After reaching the colon, olsalazine is converted into two molecules of mesalamine, allowing the medication to deliver its anti-inflammatory effects directly where ulcerative colitis commonly causes inflammation.
Mesalamine works locally within the intestinal lining and helps reduce the production of inflammatory chemicals that contribute to tissue irritation and damage. By decreasing inflammation in the colon, Dipentum may help maintain disease control and support remission in patients with ulcerative colitis.
Because the medication becomes active primarily in the colon, much of its therapeutic activity occurs directly at the site of disease involvement. This targeted action helps make Dipentum an effective maintenance treatment for many patients with ulcerative colitis.
What Conditions Does Dipentum Treat?
Dipentum is FDA-approved for the maintenance of remission of ulcerative colitis in adult patients.
Ulcerative colitis is a chronic inflammatory bowel disease that affects the lining of the colon and rectum. Symptoms may include abdominal pain, diarrhea, rectal bleeding, urgency, and fatigue during periods of active disease. Even when symptoms improve, ongoing inflammation can return, leading to future flare-ups.
Healthcare providers may prescribe Dipentum after a patient’s ulcerative colitis has entered remission. Rather than treating severe active flare-ups, the medication is intended to help maintain symptom control and reduce the likelihood of disease recurrence over time.
Benefits of Treatment
For patients whose ulcerative colitis is in remission, maintaining long-term disease control is an important treatment goal. Dipentum provides ongoing anti-inflammatory activity within the colon and is designed specifically for maintenance therapy.
Potential benefits include helping maintain remission, supporting long-term disease stability, reducing inflammatory activity within the colon, and helps decrease the likelihood of symptom recurrence. Because the medication acts locally within the digestive tract, it targets inflammation where ulcerative colitis commonly occurs.
Many patients use Dipentum as part of a long-term treatment plan under the supervision of a healthcare provider. Individual responses vary, and ongoing monitoring helps ensure the medication remains effective and well-tolerated throughout treatment.
Important Safety Information and Side Effects
Dipentum does not carry an FDA Boxed Warning. However, important safety considerations should be discussed before and during treatment. The most commonly reported side effects include diarrhea, abdominal pain, nausea, headache, rash, joint pain, fatigue, and indigestion.
Diarrhea is one of the most frequently reported side effects and may be severe enough in some patients to require dose adjustments or discontinuation of therapy. Patients should contact their healthcare provider if diarrhea becomes persistent or severe.
Aminosalicylate medications such as Dipentum have been associated with kidney impairment. Healthcare providers typically evaluate kidney function before treatment begins and monitor renal health periodically during therapy. Patients with pre-existing kidney disease may be at increased risk for kidney-related complications.
Some individuals may experience mesalamine-related acute intolerance syndrome, which can resemble a flare of ulcerative colitis. Symptoms may include abdominal pain, cramping, bloody diarrhea, fever, headache, and rash. Patients experiencing these symptoms should contact their healthcare provider promptly.
Kidney stones have been reported with mesalamine-containing products. Maintaining adequate hydration may help reduce this risk. Patients should report symptoms such as flank pain, blood in the urine, or painful urination.
Hypersensitivity reactions may occur, particularly in patients with known sensitivity to salicylates or aminosalicylates. Use caution in patients with liver disease, and appropriate monitoring may be recommended during treatment.
Patients with certain skin conditions, including eczema or atopic dermatitis, may experience increased sensitivity to sunlight while taking Dipentum. Protective measures against excessive sun exposure may be appropriate.
Women who are pregnant, planning to become pregnant, or breastfeeding should discuss treatment considerations with their healthcare provider. Olsalazine metabolites may pass into breast milk and may contribute to diarrhea in nursing infants.
Patients should provide a complete list of prescription medications, over-the-counter products, vitamins, and supplements before starting treatment because interactions may occur with other aminosalicylates, nephrotoxic medications, and certain immunosuppressive therapies.
Access to Multiple Medications
Support Beyond Dipentum
Looking for ulcerative colitis medication support as well as other medication support?
Prescription Hope helps patients access multiple brand-name medications every day. For $70.00 per month, per medication, we help patients access as many medications as they qualify for on our list of hundreds of medications.
Why Choose Prescription Hope for Dipentum Assistance
Experienced Advocacy Support
Our patient-centered assistance and prescription affordability support have helped patients across the nation for two decades.
Ongoing Affordability Assistance
Prescription Hope’s medication support services not only manage the application process from beginning to end, but also include administrative tasks necessary to maintain patient assistance program approval status.
We take care of refill schedules, document updates, yearly renewals, program monitoring, and more.
Clear Pricing
Prescription Hope’s medication application assistance and affordable medication access are included in our simple service rate of $70.00 per month, per medication.
Nationwide Network Access Support
We’ve helped patients across the nation access our network of hundreds of pharmaceutical manufacturers.
If you need Dipentum Patient Assistance Program assistance, then be sure to enroll with Prescription Hope today and find out how we can help you save!
